NCT07035457

A Study in Healthy Men to Compare the Amount of Vicadrostat and Empagliflozin in the Blood When Taken Separately and Together

Relative Bioavailability of Single Doses of Vicadrostat and Empagliflozin Administered Alone Compared to Combined Administration to Healthy Male Subjects (an Open Label, Randomised, Three-way Crossover Trial)

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 15 (actual)
• Sponsor: Boehringer Ingelheim · Industry
• Sex: Male
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The main objective of this trial is to investigate the relative bioavailability of vicadrostat and empagliflozin when administered in combination or individually.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Vicadrostat	Vicadrostat
DRUG	Jardiance®	Jardiance®

Timeline

• Start date: 2025-07-02
• Primary completion: 2025-08-07
• Completion: 2025-08-15
• First posted: 2025-06-25
• Last updated: 2025-08-20

Locations

1 site across 1 country: Germany